BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11975042)

  • 1. [Hodgkin lymphomas: current understanding of pathogenesis and pathomorphology].
    Pajor L
    Orv Hetil; 2002 Mar; 143(13):651-61. PubMed ID: 11975042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness.
    Szczepanowski M; Masqué-Soler N; Oschlies I; Schmidt W; Lück A; Klapper W
    Hum Pathol; 2013 Jul; 44(7):1434-9. PubMed ID: 23427872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
    Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current views of the histogenesis and pathogenesis of Hodgkin lymphoma].
    Leenman EE
    Arkh Patol; 2007; 69(5):7-11. PubMed ID: 18074812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
    Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease: classification and differential diagnosis.
    Harris NL
    Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioptic typing and classification of Hodgkin's lymphomas--status in 1998].
    Plank L; Fakan F
    Vnitr Lek; 1999 Mar; 45(3):186-92. PubMed ID: 15641245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
    Huang Q; Wilczynski SP; Chang KL; Weiss LM
    Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How immunologic and genetic biomarkers impact Hodgkin lymphoma classification, diagnosis, and management: a huge potential that yet needs to be exploited.
    Carbone A; Gloghini A
    Int J Biol Markers; 2018 May; 33(2):137-140. PubMed ID: 29099538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma.
    Greiner A; Tobollik S; Buettner M; Jungnickel B; Herrmann K; Kremmer E; Niedobitek G
    J Pathol; 2005 Apr; 205(5):541-7. PubMed ID: 15732141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current lymphoma classification: a step forward for pathologists and clinicians].
    de Jong D; Kluin PM
    Ned Tijdschr Geneeskd; 1997 Aug; 141(33):1601-13. PubMed ID: 9543765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease.
    Carbone A; Gloghini A
    Hum Pathol; 2012 May; 43(5):619-28. PubMed ID: 22209342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
    Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
    Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hodgkin and Reed/Sternberg cell.
    Küppers R; Hansmann ML
    Int J Biochem Cell Biol; 2005 Mar; 37(3):511-7. PubMed ID: 15618006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating germinal center-derived lymphomas through their cellular microenvironment.
    Carbone A; Gloghini A; Cabras A; Elia G
    Am J Hematol; 2009 Jul; 84(7):435-8. PubMed ID: 19484731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
    Kamper PM; Kjeldsen E; Clausen N; Bendix K; Hamilton-Dutoit S; d'Amore F
    Br J Haematol; 2005 Jun; 129(5):615-7. PubMed ID: 15916683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.